2Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
3Lepow ML,Balassanian N,Emmerich J,et al.Interrelationships of viral,mycoplasmal,and bacterial agents in uncomplicated pneumonia.Am Rev Respir Dis,1968,97:533-545.
4Lim WS,Macfarlane JT,Boswell TC,et al.Study of community acquired pneumonia aetiology(SCAPA) in adults admitted to hospital:implications for management guidelines.Thorax,2001,56:296-301.
5Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
6Heffelfinger JD,Dowell SF,Jorgensen JH,et al.Management of community-acquired pneumonia in the era of pneumococcal resistance:a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.Arch Intern Med,2000,160:1399-1408.
8Arnold FW, Summersgill JT, Lajoie AS, et al. A worldwideperspective of atypical pathogens in community-acquiredpneumonia. Am J Respir Crit Care Med, 2007,175 : 1086-1093.
9Shin GY. What about viral community acquired pneumonias?.BMJ, 2008, 337: a598.
10Cao B, Ren LL, Zhao F, et al. Viral and Mycoplasmapneumoniae community-acquired pneumonia and novel clinicaloutcome evaluation in ambulatory adult patients in China. Eur JClin Microbiol Infect Dis, 2010,29: 1443-1448.
